The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis
High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
The company has raised US$4.5 million in funding for its AI operating system
Subscribe To Our Newsletter & Stay Updated
